Moreover, recent studies have shown that circulating levels of FGF-21 are strongly associated with insulin-resistant states such as obesity and type 2 diabetes and inversely associated with both whole-body (muscle) and hepatic insulin sensitivity [9]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.